TCL Archive ‘We Cannot Tolerate One Third Reduction In Centers. Prevention, Clinical Trials Programs’ September 20, 1991
TCL Archive Health Canada Suspends Avastin Approval; CMS Has Taken No Action After FDA Decision December 2, 2011
TCL Archive An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists. May 13, 2005
TCL Archive Capitol Hill: Sen. Harkin Introduces NIH Funding Bill That Boosts Budget to $46.2 Billion by 2021 July 25, 2014
TCL Archive NAB Approves Subcommittee Recommendations On Organ Site Program – NIH Review, One Headquarters May 21, 1982
